Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.

Hatice Kubra Erkilet Deniz Gezgin Yıldırım Pelin Esmeray Şenol H Oğuz Söylemezoğlu

Published in: Pediatrics international : official journal of the Japan Pediatric Society (2023)

FMF patients with colchicine resistance may progress to amyloidosis. IL-1 antagonist treatment could be used safely with a favorable outcome in pediatric patients with FMF resistance to colchicine therapy and/or who have renal amyloidosis.

Keyphrases

multiple myeloma
young adults
early onset
stem cells
combination therapy
cell therapy
smoking cessation